Cargando…

Synthesis, structure-activity relationships and biological evaluation of benzimidazole derived sulfonylurea analogues as a new class of antagonists of P2Y1 receptor

The P2Y receptors are responsible for the regulation of various physiological processes including neurotransmission and inflammatory responses. These receptors are also considered as novel potential therapeutic targets for prevention and treatment of thrombosis, neurological disorders, pain, cardiac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bano, Sehrish, Hussain, Zahid, Langer, Peter, Weisman, Gary A., Iqbal, Jamshed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250618/ https://www.ncbi.nlm.nih.gov/pubmed/37305545 http://dx.doi.org/10.3389/fphar.2023.1217315

Ejemplares similares

Design, synthesis and biological profile of heterocyclic benzimidazole analogues as prospective antimicrobial and antiproliferative agents
por: Tahlan, Sumit, et al.
Publicado: (2019)

Design, Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Study of Benzimidazole-Based Oxazole Analogues: A Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors
por: Hussain, Rafaqat, et al.
Publicado: (2023)

A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives
por: Brishty, Shejuti Rahman, et al.
Publicado: (2021)

Synthesis and biological profile of substituted benzimidazoles
por: Vashist, Neelam, et al.
Publicado: (2018)

Sulfonylureas for Treatment of Periodontitis-Diabetes Comorbidity-Related Complications: Killing Two Birds With One Stone
por: Yang, Luxi, et al.
Publicado: (2021)

Synthesis and biological evaluation of sulfamoyl benzamide derivatives as selective inhibitors for h-NTPDases
por: Zaigham, Zahid Hussain, et al.
Publicado: (2023)

Synthesis of Benzimidazole-Sulfonyl Derivatives and Their Biological Activities
por: Mulugeta, Endale, et al.
Publicado: (2022)

Treatment Dynamics in People Who Initiate Metformin or Sulfonylureas for Type 2 Diabetes: A National Cohort Study
por: Wood, Stephen, et al.
Publicado: (2021)

Synthesis, characterization and in vitro, in vivo, in silico biological evaluations of substituted benzimidazole derivatives
por: Raka, Sabreena Chowdhury, et al.
Publicado: (2022)

The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels
por: Cunningham, Kevin P., et al.
Publicado: (2021)

Synthesis of Antimicrobial Benzimidazole–Pyrazole Compounds and Their Biological Activities
por: Marinescu, Maria
Publicado: (2021)

Calenduloside E Analogues Protecting H9c2 Cardiomyocytes Against H(2)O(2)-Induced Apoptosis: Design, Synthesis and Biological Evaluation
por: Tian, Yu, et al.
Publicado: (2017)

Antiparasitic Behavior of Trifluoromethylated Pyrazole 2-Amino-1,3,4-thiadiazole Hybrids and Their Analogues: Synthesis and Structure-Activity Relationship
por: Camargo, Jeniffer do Nascimento Ascencio, et al.
Publicado: (2020)

Appraisal of novel azomethine–thioxoimidazolidinone conjugates as ecto-5′-nucleotidase inhibitors: synthesis and molecular docking studies
por: Channar, Pervaiz Ali, et al.
Publicado: (2022)

Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study
por: Roberto, Giuseppe, et al.
Publicado: (2022)

Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43)
por: Schrijnders, Dennis, et al.
Publicado: (2016)

Synthesis, Characterization, and Biological Evaluation of Benzimidazole Derivatives as Potential Anxiolytics
por: Nannapaneni, DT, et al.
Publicado: (2010)

Absorption, Metabolism, and Excretion of ACT-1004-1239, a First-In-Class CXCR7 Antagonist: In Vitro, Preclinical, and Clinical Data
por: Huynh, Christine, et al.
Publicado: (2022)

Novel Sulfonylurea Derivatives as Potential Antimicrobial Agents: Chemical Synthesis, Biological Evaluation, and Computational Study
por: Meng, Fan-Fei, et al.
Publicado: (2023)

Development of I(KATP) Ion Channel Blockers Targeting Sulfonylurea Resistant Mutant K(IR)6.2 Based Channels for Treating DEND Syndrome
por: Houtman, Marien J. C., et al.
Publicado: (2022)

Biological Activity and Molecular Structures of Bis(benzimidazole) and Trithiocyanurate Complexes
por: Kopel, Pavel, et al.
Publicado: (2015)

Editorial: Metalloenzymes: Potential Drug Targets
por: Iqbal, Jamshed, et al.
Publicado: (2021)

Solvent-Free Synthesis and Safener Activity of Sulfonylurea Benzothiazolines
por: Fu, Ying, et al.
Publicado: (2017)

Synthesis and Biological Evaluation of 1,3-Dideazapurine-Like 7-Amino-5-Hydroxymethyl-Benzimidazole Ribonucleoside Analogues as Aminoacyl-tRNA Synthetase Inhibitors
por: Zhang, Baole, et al.
Publicado: (2020)

Antihypertensive Effect of a Novel Angiotensin II Receptor Blocker Fluorophenyl Benzimidazole: Contribution of cGMP, Voltage-dependent Calcium Channels, and BK(Ca) Channels to Vasorelaxant Mechanisms
por: Iqbal, Hina, et al.
Publicado: (2021)

Design, computational studies, synthesis and in vitro antimicrobial evaluation of benzimidazole based thio-oxadiazole and thio-thiadiazole analogues
por: Noureldin, Nada A., et al.
Publicado: (2021)

Substituted Benzimidazole Analogues as Potential α-Amylase Inhibitors and Radical Scavengers
por: Akande, Akinsola Adegboye, et al.
Publicado: (2021)

GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers
por: Christensen, Alexander S., et al.
Publicado: (2020)

Biological Evaluation, Molecular Docking, and SAR Studies of Novel 2-(2,4-Dihydroxyphenyl)-1H- Benzimidazole Analogues
por: Matysiak, Joanna, et al.
Publicado: (2019)

Relationship between intraocular pressure lowering effect and chemical structure of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole derivatives
por: Vassiliev, Pavel, et al.
Publicado: (2018)

Multipotent Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease: Synthesis, Biological Analysis and Molecular Docking Study of Benzimidazole-Based Thiazole Derivatives
por: Hussain, Rafaqat, et al.
Publicado: (2022)

Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
por: Zhou, Lin, et al.
Publicado: (2022)

Taccalonolides: Structure, semi-synthesis, and biological activity
por: Li, Yan, et al.
Publicado: (2022)

Ortho versus Meta Chlorophenyl-2,3-Benzodiazepine Analogues: Synthesis, Molecular Modeling, and Biological Activity as AMPAR Antagonists
por: Qneibi, Mohammad, et al.
Publicado: (2020)

Design and Synthesis of Novel Nordihydroguaiaretic Acid (NDGA) Analogues as Potential FGFR1 Kinase Inhibitors With Anti-Gastric Activity and Chemosensitizing Effect
por: Chen, Qian, et al.
Publicado: (2020)

Sulfonylureas: Asset or liability?
por: Lakhani, Om J., et al.
Publicado: (2015)

Sulfonylureas at the Glomerular Battlefield
por: Kalra, Sanjay, et al.
Publicado: (2018)

Design, Synthesis, and Biological Evaluation of Benzimidazole Derivatives as Potential Lassa Virus Inhibitors
por: Chen, Jinwei, et al.
Publicado: (2023)

Editorial: Erythropoietin and Its Analogues as Therapeutics for Neurological Diseases
por: Brines, Michael, et al.
Publicado: (2022)

Synthesis and Biological Evaluation of 2-Phenoxyacetamide Analogues, a Novel Class of Potent and Selective Monoamine Oxidase Inhibitors
por: Shen, Wei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l0ibduagp690ajc06aja18ej3t